Stocks and Investing Stocks and Investing
Tue, April 26, 2016
Mon, April 25, 2016
Fri, April 22, 2016
Thu, April 21, 2016
Wed, April 20, 2016
Tue, April 19, 2016
Mon, April 18, 2016
Sun, April 17, 2016
Fri, April 15, 2016
Thu, April 14, 2016
Wed, April 13, 2016
Tue, April 12, 2016
Mon, April 11, 2016
Fri, April 8, 2016
Thu, April 7, 2016
Wed, April 6, 2016

Hartaj Singh Maintained (SRPT) at Buy with Increased Target to $60 on, Apr 6th, 2016


Published on 2024-10-25 12:09:48 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $45 to $60 on, Apr 6th, 2016.

Hartaj has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Hartaj's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $15 on, Tuesday, January 19th, 2016